BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17947082)

  • 1. Development of an algorithm for detection of fatal cardiac arrhythmia for implantable cardioverter-defibrillator using a self-organizing map.
    Kinoshita H; Yoshizawa M; Inagaki M; Uemura K; Sugimachi M; Sunagawa K
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():4370-3. PubMed ID: 17947082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving contemporary algorithms for implantable cardioverter-defibrillator function.
    Shome S; Li D; Thompson J; McCabe A
    J Electrocardiol; 2010; 43(6):503-8. PubMed ID: 20719333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Sudden Cardiac Death in Implantable Cardioverter Defibrillators: A Review and Comparative Study of Heart Rate Variability Features.
    Parsi A; O'Loughlin D; Glavin M; Jones E
    IEEE Rev Biomed Eng; 2020; 13():5-16. PubMed ID: 31021774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods of ambulatory detection and treatment of cardiac arrhythmias using implantable cardioverter-defibrillators.
    Shrivastav M
    Biomed Instrum Technol; 1999; 33(6):505-21. PubMed ID: 10626042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.
    Thakor NV; Natarajan A
    Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators.
    Karnik AA; Helm RH; Monahan KM
    J Cardiovasc Electrophysiol; 2019 Mar; 30(3):402-409. PubMed ID: 30576031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fuzzy logic-based diagnostic algorithm for implantable cardioverter defibrillators.
    Bárdossy A; Blinowska A; Kuzmicz W; Ollitrault J; Lewandowski M; Przybylski A; Jaworski Z
    Artif Intell Med; 2014 Feb; 60(2):113-21. PubMed ID: 24503486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
    Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual chamber arrhythmia detection in the implantable cardioverter defibrillator.
    Dijkman B; Wellens HJ
    J Cardiovasc Electrophysiol; 2000 Oct; 11(10):1105-15. PubMed ID: 11059974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm.
    Sueda S; Kohno H
    Intern Med; 2018 May; 57(10):1361-1369. PubMed ID: 29321418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
    Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patients with an implantable defibrillator live longer?
    Böcker D; Block M; Isbruch F; Wietholt D; Hammel D; Borggrefe M; Breithardt G
    J Am Coll Cardiol; 1993 Jun; 21(7):1638-44. PubMed ID: 8496531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of death in chronic kidney disease: the role of implantable cardioverter defibrillators.
    Turner S; Onalan O; Bickle B
    CANNT J; 2009; 19(3):29-36; quiz 37-8. PubMed ID: 19899497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the wearable cardioverter defibrillator in clinical practice.
    Chung MK
    Cardiol Clin; 2014 May; 32(2):253-70. PubMed ID: 24793801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsustained ventricular tachycardia and other high-risk predictors following myocardial infarction: implications for prophylactic automatic implantable cardioverter-defibrillator use.
    Wilber DJ; Kopp D; Olshansky B; Kall JG; Kinder C
    Prog Cardiovasc Dis; 1993; 36(3):179-94. PubMed ID: 8234772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.